BioCentury | Oct 6, 2016
Distillery Therapeutics
Therapeutics: TRAF2 and NCK interacting kinase (TNIK)
...inhibiting TNIK could help treat colorectal cancer. In a human colorectal carcinoma cell line, the TNIK...
...the safety of NCB-0846. Carna Biosciences Inc. has NCB-0846 in preclinical testing for cancer. TARGET/MARKER/PATHWAY: TRAF2 and NCK interacting kinase (TNIK)...
...the safety of NCB-0846. Carna Biosciences Inc. has NCB-0846 in preclinical testing for cancer. TARGET/MARKER/PATHWAY: TRAF2 and NCK interacting kinase (TNIK)...